• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于过饱和的药物传递系统:提高难溶性药物生物利用度的策略。

Supersaturation-Based Drug Delivery Systems: Strategy for Bioavailability Enhancement of Poorly Water-Soluble Drugs.

机构信息

Chitkara College of Pharmacy, Chitkara University, Rajpura 140401, Punjab, India.

Faculty of Medicine and Pharmacy, University of Oradea, P-ta 1 Decembrie 10, 410087 Oradea, Romania.

出版信息

Molecules. 2022 May 6;27(9):2969. doi: 10.3390/molecules27092969.

DOI:10.3390/molecules27092969
PMID:35566319
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9101434/
Abstract

At present, the majority of APIs synthesized today remain challenging tasks for formulation development. Many technologies are being utilized or explored for enhancing solubility, such as chemical modification, novel drug delivery systems (microemulsions, nanoparticles, liposomes, etc.), salt formation, and many more. One promising avenue attaining attention presently is supersaturated drug delivery systems. When exposed to gastrointestinal fluids, drug concentration exceeds equilibrium solubility and a supersaturation state is maintained long enough to be absorbed, enhancing bioavailability. In this review, the latest developments in supersaturated drug delivery systems are addressed in depth.

摘要

目前,大多数合成的 API 仍然是制剂开发的难题。许多技术被用于或探索用于提高溶解度,例如化学修饰、新型药物传递系统(微乳液、纳米粒、脂质体等)、盐形成等。目前受到关注的一个有前途的途径是过饱和药物传递系统。当暴露于胃肠液中时,药物浓度超过平衡溶解度,并且保持过饱和状态足够长的时间以被吸收,从而提高生物利用度。在这篇综述中,深入探讨了过饱和药物传递系统的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/9101434/5a88246aa3a0/molecules-27-02969-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/9101434/7a763c7baea1/molecules-27-02969-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/9101434/c033bdcd558f/molecules-27-02969-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/9101434/5a88246aa3a0/molecules-27-02969-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/9101434/7a763c7baea1/molecules-27-02969-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/9101434/c033bdcd558f/molecules-27-02969-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d09f/9101434/5a88246aa3a0/molecules-27-02969-g003.jpg

相似文献

1
Supersaturation-Based Drug Delivery Systems: Strategy for Bioavailability Enhancement of Poorly Water-Soluble Drugs.基于过饱和的药物传递系统:提高难溶性药物生物利用度的策略。
Molecules. 2022 May 6;27(9):2969. doi: 10.3390/molecules27092969.
2
Bioavailability Improvement Strategies for Poorly Water-Soluble Drugs Based on the Supersaturation Mechanism: An Update.基于过饱和机制的难溶性药物生物利用度提高策略:最新进展
J Pharm Pharm Sci. 2016 Apr-Jun;19(2):208-25. doi: 10.18433/J3W904.
3
Pharmaceutical Methods for Enhancing the Dissolution of Poorly Water-Soluble Drugs.提高难溶性药物溶出度的药学方法。
Assay Drug Dev Technol. 2023 Feb-Mar;21(2):65-79. doi: 10.1089/adt.2022.119.
4
Lipid-based systems as a promising approach for enhancing the bioavailability of poorly water-soluble drugs.基于脂质的系统作为提高难溶性药物生物利用度的一种有前景的方法。
Acta Pharm. 2013 Dec;63(4):427-45. doi: 10.2478/acph-2013-0040.
5
Stabilizing supersaturated drug-delivery system through mechanism of nucleation and crystal growth inhibition of drugs.通过药物成核和晶体生长抑制机制稳定过饱和药物递送系统。
Ther Deliv. 2018 Nov;9(12):873-885. doi: 10.4155/tde-2018-0031.
6
Oral bioavailability enhancement through supersaturation: an update and meta-analysis.通过过饱和提高口服生物利用度:最新进展与荟萃分析。
Expert Opin Drug Deliv. 2017 Mar;14(3):403-426. doi: 10.1080/17425247.2016.1218465. Epub 2016 Aug 11.
7
Current Trends in Self-Emulsifying Drug Delivery Systems (SEDDSs) to Enhance the Bioavailability of Poorly Water-Soluble Drugs.提高难溶性药物生物利用度的自乳化药物递送系统(SEDDSs)的当前趋势
Crit Rev Ther Drug Carrier Syst. 2016;33(1):1-39. doi: 10.1615/CritRevTherDrugCarrierSyst.v33.i1.20.
8
Supersaturating drug delivery systems: the answer to solubility-limited oral bioavailability?超饱和药物递送系统:解决溶解度限制口服生物利用度的方法?
J Pharm Sci. 2009 Aug;98(8):2549-72. doi: 10.1002/jps.21650.
9
The antisolvent coprecipitation method for enhanced bioavailability of poorly water-soluble drugs.用于提高难溶性药物生物利用度的抗溶剂共沉淀法。
Int J Pharm. 2022 Oct 15;626:122043. doi: 10.1016/j.ijpharm.2022.122043. Epub 2022 Jul 25.
10
Recent strategies in spray drying for the enhanced bioavailability of poorly water-soluble drugs.喷雾干燥法提高难溶性药物生物利用度的最新策略。
J Control Release. 2018 Jan 10;269:110-127. doi: 10.1016/j.jconrel.2017.11.005. Epub 2017 Nov 5.

引用本文的文献

1
Combination Drug Product of Amorphous Solid Dispersion Show Extended Supersaturation and Enhanced Dissolution.无定形固体分散体组合药物产品显示出延长的过饱和和增强的溶解。
AAPS PharmSciTech. 2025 May 30;26(5):152. doi: 10.1208/s12249-025-03126-3.
2
Physicochemical Properties and Molecular Insights of Favipiravir and Roflumilast Solid Dispersions for COVID-19 Treatment.用于治疗新冠肺炎的法匹拉韦和罗氟司特固体分散体的物理化学性质及分子见解
Pharmaceuticals (Basel). 2025 Apr 18;18(4):590. doi: 10.3390/ph18040590.
3
Soluplus-Based Pharmaceutical Formulations: Recent Advances in Drug Delivery and Biomedical Applications.

本文引用的文献

1
Preparation and Evaluation of Novel Supersaturated Solid Dispersion of Magnolol : Theme: Advancements in Amorphous Solid Dispersions to Improve Bioavailability.新型厚朴酚超饱和固体分散体的制备与评价:主题:提高生物利用度的无定形固体分散体的进展。
AAPS PharmSciTech. 2022 Mar 24;23(4):97. doi: 10.1208/s12249-022-02251-7.
2
Eutectic mixture and amorphous solid dispersion: Two different supersaturating drug delivery system strategies to improve griseofulvin release using saccharin.共晶混合物和无定形固体分散体:两种不同的超饱和药物传递系统策略,使用糖精提高灰黄霉素的释放。
Int J Pharm. 2022 Mar 5;615:121498. doi: 10.1016/j.ijpharm.2022.121498. Epub 2022 Jan 20.
3
基于Soluplus的药物制剂:药物递送与生物医学应用的最新进展
Int J Mol Sci. 2025 Feb 11;26(4):1499. doi: 10.3390/ijms26041499.
4
Co-Amorphization, Dissolution, and Stability of Quench-Cooled Drug-Drug Coamorphous Supersaturating Delivery Systems with RT-Unstable Amorphous Components.具有室温不稳定无定形成分的骤冷药物-药物共无定形过饱和递送系统的共无定形化、溶解和稳定性
Pharmaceutics. 2024 Nov 21;16(12):1488. doi: 10.3390/pharmaceutics16121488.
5
Nanoformulations in Pharmaceutical and Biomedical Applications: Green Perspectives.纳米制剂在药物和生物医学应用中的应用:绿色视角。
Int J Mol Sci. 2024 May 27;25(11):5842. doi: 10.3390/ijms25115842.
6
Solid dispersion systems for enhanced dissolution of poorly water-soluble candesartan cilexetil: In vitro evaluation and simulated pharmacokinetics studies.固体分散体系统提高难溶性坎地沙坦西酯的溶出度:体外评价和模拟药代动力学研究。
PLoS One. 2024 Jun 6;19(6):e0303900. doi: 10.1371/journal.pone.0303900. eCollection 2024.
7
Strategies to Improve the Transdermal Delivery of Poorly Water-Soluble Non-Steroidal Anti-Inflammatory Drugs.改善难溶性非甾体抗炎药经皮给药的策略
Pharmaceutics. 2024 May 16;16(5):675. doi: 10.3390/pharmaceutics16050675.
8
Design and Synthesis of Dimethylaminomethyl-Substituted Curcumin Derivatives: Potent Anti-Inflammatory, Anti-Oxidant, and Radioprotection Activity, Improved Aqueous Solubility Compared with Curcumin.二甲胺甲基取代姜黄素衍生物的设计与合成:具有较强的抗炎、抗氧化和放射防护活性,与姜黄素相比水溶性得到改善。
Molecules. 2024 Apr 26;29(9):1985. doi: 10.3390/molecules29091985.
9
Simple preparation and greatly improved oral bioavailability: The supersaturated drug delivery system of quercetin based on PVP K30.简单的制备方法与显著提高的口服生物利用度:基于聚乙烯吡咯烷酮K30的槲皮素过饱和药物递送系统
Drug Deliv Transl Res. 2024 Nov;14(11):3225-3238. doi: 10.1007/s13346-024-01544-7. Epub 2024 Feb 29.
10
Development of Gefitinib-Loaded Solid Lipid Nanoparticles for the Treatment of Breast Cancer: Physicochemical Evaluation, Stability, and Anticancer Activity in Breast Cancer (MCF-7) Cells.用于治疗乳腺癌的吉非替尼载药固体脂质纳米粒的研发:物理化学评估、稳定性及对乳腺癌(MCF-7)细胞的抗癌活性
Pharmaceuticals (Basel). 2023 Nov 2;16(11):1549. doi: 10.3390/ph16111549.
A Customized Screening Tool Approach for the Development of a Self-Nanoemulsifying Drug Delivery System (SNEDDS).
定制筛选工具方法在自微乳药物传递系统(SNEDDS)开发中的应用。
AAPS PharmSciTech. 2021 Dec 27;23(1):39. doi: 10.1208/s12249-021-02176-7.
4
In Vitro Evaluation of a Solid Supersaturated Self Nanoemulsifying Drug Delivery System (Super-SNEDDS) of Aprepitant for Enhanced Solubility.阿瑞匹坦固体过饱和自纳米乳化药物递送系统(Super-SNEDDS)的体外溶解度增强评价
Pharmaceuticals (Basel). 2021 Oct 27;14(11):1089. doi: 10.3390/ph14111089.
5
Preparation and Evaluation of Self-emulsifying Drug Delivery System (SEDDS) of Cepharanthine.盐酸塞拉嗪自乳化药物传递系统的制备与评价。
AAPS PharmSciTech. 2021 Oct 5;22(7):245. doi: 10.1208/s12249-021-02085-9.
6
Supersaturating drug delivery systems containing fixed-dose combination of two antihypertensive drugs: Formulation, in vitro evaluation and molecular metadynamics simulations.含有两种抗高血压药物固定剂量组合的过饱和给药系统:制剂、体外评价及分子元动力学模拟
Eur J Pharm Sci. 2021 Aug 1;163:105860. doi: 10.1016/j.ejps.2021.105860. Epub 2021 Apr 24.
7
A mechanistic review on the dissolution phase behavior and supersaturation stabilization of amorphous solid dispersions.关于无定形固体分散体溶解相行为和过饱和稳定的机制综述。
Drug Dev Ind Pharm. 2021 Jan;47(1):1-11. doi: 10.1080/03639045.2021.1879843. Epub 2021 Feb 5.
8
Interaction with biliary and pancreatic fluids drives supersaturation and drug absorption from lipid-based formulations of low (saquinavir) and high (fenofibrate) permeability poorly soluble drugs.与胆汁和胰液的相互作用会导致低(沙奎那韦)和高(非诺贝特)通透性的疏水性药物的基于脂质的制剂发生过饱和,并影响药物的吸收。
J Control Release. 2021 Mar 10;331:45-61. doi: 10.1016/j.jconrel.2021.01.007. Epub 2021 Jan 12.
9
Exploring precipitation inhibitors to improve in vivo absorption of cinnarizine from supersaturated lipid-based drug delivery systems.探索沉淀抑制剂以提高辛尼嗪从超饱和脂质给药系统的体内吸收。
Eur J Pharm Sci. 2021 Apr 1;159:105691. doi: 10.1016/j.ejps.2020.105691. Epub 2020 Dec 24.
10
Current Status of Supersaturable Self-Emulsifying Drug Delivery Systems.过饱和自乳化药物递送系统的现状
Pharmaceutics. 2020 Apr 16;12(4):365. doi: 10.3390/pharmaceutics12040365.